LDL-lowering
Search documents
NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2026 Conference Transcript
2026-03-09 13:42
NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2026 Conference March 09, 2026 08:40 AM ET Company ParticipantsIan Somaiya - CFOMichael Davidson - CEOConference Call ParticipantsRoanna Ruiz - Senior Biotech AnalystRoanna RuizOkay, great. I think we're at time, I'll kick it off. Hey, everybody. I'm Roanna Ruiz, one of the Senior Biotech Analysts here at Leerink Partners. Just wanna welcome everybody to our global healthcare conference, it's my pleasure to introduce NewAmsterdam Pharma. I've got the CEO, Michael ...